Status:
UNKNOWN
Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction in Coronavirus Disease 2019 (COVID19) Survivors
Lead Sponsor:
The University of Hong Kong
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Coronavirus Disease 2019 (COVID-19) emerged in December 2019, and in mere few months has resulted in a pandemic of viral pneumonia. Substantial proportion of patients with COVID-19 have biochemical ev...
Detailed Description
Coronavirus Disease 2019 (COVID-19) emerged in December 2019, and in mere few months has resulted in a pandemic of viral pneumonia. As of April 2020, over 2 million populations were infected and more ...
Eligibility Criteria
Inclusion
- Survivors of PCR-confirmed COVID-19
- 2-6 weeks after hospital discharge with 2 consecutive negative polymerase chain reaction (PCR) for severe acute respiratory syndrome (SARS) coronavirus (CoV)-2.
Exclusion
- Pre-existing heart failure
- Pre-existing left ventricular systolic dysfunction (left ventricular ejection fraction \< 50%)
- Pre-existing atrial fibrillation
- Failure to provide informed consent
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04355884
Start Date
April 20 2020
End Date
May 1 2020
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Hong Kong, Queen Mary Hospital
Hong Kong, Hong Kong